Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia
about
Economic evaluation of paliperidone palmitate once monthly for treating chronic schizophrenia patients in the United Arab Emirates.Efficacy and safety profile of paliperidone palmitate injections in the management of patients with schizophrenia: an evidence-based review.Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
P2860
Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
name
Adherence, healthcare resource ...... y diagnosed with schizophrenia
@ast
Adherence, healthcare resource ...... y diagnosed with schizophrenia
@en
type
label
Adherence, healthcare resource ...... y diagnosed with schizophrenia
@ast
Adherence, healthcare resource ...... y diagnosed with schizophrenia
@en
prefLabel
Adherence, healthcare resource ...... y diagnosed with schizophrenia
@ast
Adherence, healthcare resource ...... y diagnosed with schizophrenia
@en
P2093
P2860
P1433
P1476
Adherence, healthcare resource ...... y diagnosed with schizophrenia
@en
P2093
Bruno Emond
Erik Muser
Kruti Joshi
Patrick Lefebvre
Rhiannon Kamstra
P2860
P2888
P356
10.1186/S12888-017-1358-3
P577
2017-06-02T00:00:00Z
P6179
1085753630